Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease

Ann Neurol. 1989 Jun;25(6):607-14. doi: 10.1002/ana.410250613.

Abstract

A 53-year-old physician who had a 10-year history of progressive idiopathic parkinsonism survived for 4 months after an autologous adrenal-medulla-to-right-caudate autograft but he received little clinical benefit. A small number of chromaffin cells in the graft site survived; they expressed neurofilament proteins and chromogranin A, but scant tyrosine hydroxylase. The striatum on both sides showed almost complete loss of [3H]mazindol binding to dopamine-uptake sites; the density of dopamine receptors was decreased adjacent to the transplant but increased rostral to the transplant. These results demonstrate that autografted chromaffin cells can survive for 4 months after transplantation and that related changes in dopamine receptors can be quantified.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Medulla / transplantation*
  • Autoradiography
  • Caudate Nucleus / pathology
  • Caudate Nucleus / surgery*
  • Chromaffin System / pathology
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Parkinson Disease / pathology
  • Parkinson Disease / surgery*
  • Transplantation, Autologous